Peters J R, Elliott J M, Grahame-Smith D G
Lancet. 1979 Nov 3;2(8149):933-6. doi: 10.1016/s0140-6736(79)92626-6.
Characteristics of receptor sites on platelets for noradrenaline (NA) and serotonin (5-HT) changed significantly between day 21 and day 28 of treatment in healthy women taking oral contraceptives. NA-induced and 5-HT-induced platelet aggregation and 5-HT uptake vaired accordingly. In untreated women with normal cycles no changes in either receptor site or in platelet function occurred between the luteal and postmenstrual phases. It is concluded that the observed changes are due to a pharmacological effect of the oral contraceptive rather than a normal physiological variation.
在服用口服避孕药的健康女性中,去甲肾上腺素(NA)和5-羟色胺(5-HT)在血小板上的受体位点特征在治疗的第21天到第28天之间发生了显著变化。NA诱导的和5-HT诱导的血小板聚集以及5-HT摄取也相应改变。在月经周期正常的未治疗女性中,黄体期和月经后期之间受体位点或血小板功能均未发生变化。得出的结论是,观察到的变化是口服避孕药的药理作用所致,而非正常的生理变异。